Skip to main content
. 2017 Jan 22;6(1):e003795. doi: 10.1161/JAHA.116.003795

Table 1.

Baseline Variables for the Different Subgroups

Characteristics All ECV Normal, LVMI Low ECV Normal, LVMI High ECV Increased, LVMI Low ECV Increased, LVMI High P Value
No., n 77 20 20 20 17 0.95
Age, y 53 (26–60) 48 (25–59) 47 (24–60) 54 (48–63) 54 (31–60) 0.65
Female sex 38 (49) 10 (50) 10 (50) 9 (45) 9 (53) 0.99
LVM, g 102 (85–126) 83 (80–90) 139 (124–156) 86 (75–95) 117 (102–138) <0.001
LVMI, g/m2 55 (45–68) 45 (43–46) 75 (68–78) 46 (42–50) 64 (59–74) <0.001
ECV, % 28.5±3.8 26.3±1.8 24.9±2.4 30.9±2.6 32.3±2.6 <0.001
EDV, mL 149.0±37.0 136.2±28.6 164.6±34.4 137.2±39.3 159.6±38.9 0.02
EDVI, mL/m2 79.3±17.1 72.6±14.3 86.2±12.7 71.7±18.0 87.9±17.5 0.001
LVEF, % 63 (57–67) 64 (59–68) 62 (57–67) 63 (58–69) 60 (52–66) 0.52
LVM/EDV2/3, g/mL2/3 3.9±0.9 3.3±0.5 4.8±0.8 3.4±0.5 4.2±0.7 <0.001
BMI, kg/m2 25.2 (22.8–28.1) 24.6 (22.7–27.7) 25.3 (23.6–28.1) 26.7 (24.8–28.2) 24.1 (21.6–27.9) 0.43
Body fat, % 30.1±7.2 28.9±8.4 29.8±9.2 31.7±4.9 29.8±4.9 0.63
BSA, m2 1.9±0.2 1.9±0.2 1.9±0.2 1.9±0.2 1.8±0.2 0.54
Hypertension 26 (34) 8 (40) 4 (20) 6 (30) 8 (47) 0.64
Diabetes mellitus 7 (9) 0 (0) 2 (10) 1 (5) 4 (24) 0.17
Smoking status
Current smoker 8 (10) 0 (0) 3 (15) 2 (10) 3 (18) 0.39
Ex‐smoker 28 (36) 10 (50) 6 (30) 6 (30) 6 (35) 0.63
Medication
Beta‐blockers 19 (25) 6 (30) 4 (20) 3 (15) 6 (35) 0.70
ACEi/ARB 18 (23) 3 (15) 7 (35) 3 (15) 5 (29) 0.49
Diuretics 29 (38) 6 (30) 9 (45) 7 (35) 7 (41) 0.88

Continuous data are given as mean±SD, median (interquartile range), or number (%). ACEi indicates angiotensin‐converting enzyme inhibitors; ARB, angiotensin II receptor blocker; BMI, body mass index; BSA, body surface area; CMR, cardiovascular magnetic resonance; ECV, extracellular volume fraction; EDV, end‐diastolic volume; EDVI, end‐diastolic volume index; LVEF, left ventricular ejection fraction; LVM, left ventricular mass; LVMI, left ventricular mass index.